Literature DB >> 16721836

Activity of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in the sera of patients with breast cancer.

Wojciech Jelski1, Lech Chrostek, Wlodzimierz Markiewicz, Maciej Szmitkowski.   

Abstract

Numerous experiments have shown that alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) play a significant role in the metabolism of many biological substances. Some metabolic disorders that can lead to breast carcinogenesis may be the cause of changes in ADH and ALDH activity. In previous experiments we found a changed level of class I ADH activity in breast cancer tissues. The changed level of this enzyme in cancer cells may be reflected by the enzyme's activity in the serum. Therefore, in this study we measured the activity of ADH isoenzymes and ALDH in the sera of patients with breast cancer. Serum samples were taken for routine biochemical investigation from 45 women with breast cancer before treatment. Among all tested classes of ADH isoenzymes, only class I had higher activity in the serum of patients with breast cancer in stage IV. The total ADH and ALDH activities were not significantly higher in patients with breast cancer than in healthy controls. The changes in activity, especially in class I ADH, appear to be caused by isoenzymes being released from the organ damaged by metastatic disease. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16721836      PMCID: PMC6807476          DOI: 10.1002/jcla.20109

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  14 in total

Review 1.  Main ethanol metabolizing alcohol dehydrogenases (ADH I and ADH IV): biochemical functions and the physiological manifestation.

Authors:  I P Ashmarin; R A Danilova; M F Obukhova; T A Moskvitina; V N Prosorovsky
Journal:  FEBS Lett       Date:  2000-12-01       Impact factor: 4.124

Review 2.  Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms.

Authors:  K W Singletary; S M Gapstur
Journal:  JAMA       Date:  2001-11-07       Impact factor: 56.272

3.  The activity of class I and II alcohol dehydrogenase isoenzymes in the sera of patients with liver tumours.

Authors:  L Chrostek; M Szmitkowski
Journal:  Clin Chem Lab Med       Date:  2000-05       Impact factor: 3.694

Review 4.  Alcohol dehydrogenases: a family of isozymes with differential functions.

Authors:  R S Holmes
Journal:  Alcohol Alcohol Suppl       Date:  1994

Review 5.  Enzymology of ethanol and acetaldehyde metabolism in mammals.

Authors:  H Riveros-Rosas; A Julian-Sanchez; E Pinã
Journal:  Arch Med Res       Date:  1997       Impact factor: 2.235

6.  Alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) activity in the human pancreas.

Authors:  Lech Chrostek; Wojciech Jelski; Maciej Szmitkowski; Zbigniew Puchalski
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

7.  Catalytic properties of human liver alcohol dehydrogenase isoenzymes.

Authors:  W F Bosron; T K Li
Journal:  Enzyme       Date:  1987

8.  Class I alcohol dehydrogenase is highly expressed in normal human mammary epithelium but not in invasive breast cancer: implications for breast carcinogenesis.

Authors:  Elise A Triano; Leslie B Slusher; Trudy A Atkins; John T Beneski; Shelley A Gestl; Reza Zolfaghari; Rathnagiri Polavarapu; Elizabeth Frauenhoffer; Judith Weisz
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

9.  The activity of class I, II, III, and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in colorectal cancer.

Authors:  Wojciech Jelski; Bogdan Zalewski; Lech Chrostek; Maciej Szmitkowski
Journal:  Dig Dis Sci       Date:  2004-06       Impact factor: 3.199

10.  Interaction between alcohol dehydrogenase II gene, alcohol consumption, and risk for breast cancer.

Authors:  T Stürmer; S Wang-Gohrke; V Arndt; H Boeing; X Kong; R Kreienberg; H Brenner
Journal:  Br J Cancer       Date:  2002-08-27       Impact factor: 7.640

View more
  8 in total

1.  Identification of cancer-associated gene clusters and genes via clustering penalization.

Authors:  Shuangge Ma; Jian Huang; Shihao Shen
Journal:  Stat Interface       Date:  2009-01-01       Impact factor: 0.582

2.  ADH1C Ile350Val polymorphism and cancer risk: evidence from 35 case-control studies.

Authors:  Yao Xue; Meilin Wang; Dongyan Zhong; Na Tong; Haiyan Chu; Xiaojing Sheng; Zhengdong Zhang
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

3.  Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses.

Authors:  Byung-Joon Park; Mee-Kyung Cha; Il-Han Kim
Journal:  BMC Res Notes       Date:  2014-01-06

4.  Discovering gene re-ranking efficiency and conserved gene-gene relationships derived from gene co-expression network analysis on breast cancer data.

Authors:  Marilena M Bourdakou; Emmanouil I Athanasiadis; George M Spyrou
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

Review 5.  Alcohol dehydrogenase and aldehyde dehydrogenase in malignant neoplasms.

Authors:  Karolina Orywal; Maciej Szmitkowski
Journal:  Clin Exp Med       Date:  2016-02-17       Impact factor: 3.984

6.  A Novel Detection Method of Breast Cancer through a Simple Panel of Biomarkers.

Authors:  Alinne T F Silva; Cláudia M Rodrigues; Izabella C C Ferreira; Letícia L D Santos; Donizeti W Santos; Thaise G Araújo; Paula P L Canto; Carlos E Paiva; Luiz R Goulart; Yara C P Maia
Journal:  Int J Mol Sci       Date:  2022-10-09       Impact factor: 6.208

7.  Lysine-specific demethylase 1 in breast cancer cells contributes to the production of endogenous formaldehyde in the metastatic bone cancer pain model of rats.

Authors:  Jia Liu; Feng-Yu Liu; Zhi-Qian Tong; Zhi-Hua Li; Wen Chen; Wen-Hong Luo; Hui Li; Hong-Jun Luo; Yan Tang; Jun-Min Tang; Jie Cai; Fei-Fei Liao; You Wan
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

8.  ALDH1 Cancer Stem Cell Marker as a Prognostic Factor in Triple-Negative Breast Cancer.

Authors:  Sonar Soni Panigoro; Dian Kurnia; Ahmad Kurnia; Samuel Johny Haryono; Zafiral Azdi Albar
Journal:  Int J Surg Oncol       Date:  2020-07-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.